These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 3193412

  • 1. Prostaglandin E2 suppositories as a second-trimester abortifacient.
    Rakhshani R, Grimes DA.
    J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
    [Abstract] [Full Text] [Related]

  • 2. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL, Valley MT, Rayburn WF, Carey JC.
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA, Hanson FW.
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [Abstract] [Full Text] [Related]

  • 4. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL, Bolognese RJ.
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [Abstract] [Full Text] [Related]

  • 5. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J, Hauth JC.
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [Abstract] [Full Text] [Related]

  • 6. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
    Shapira S, Goldberger S, Beyth Y, Fejgin MD.
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
    [Abstract] [Full Text] [Related]

  • 7. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS, Haag MK.
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [Abstract] [Full Text] [Related]

  • 8. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
    Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM.
    Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
    [Abstract] [Full Text] [Related]

  • 9. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH.
    J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of dinoprostone gel and gemeprost suppositories for induction of abortion in the second and third trimester].
    Mink D, Heiss C, Rothbrust S, Schmidt W.
    Zentralbl Gynakol; 1995 Jul; 117(5):263-8. PubMed ID: 7793169
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL, Poole CP, Gookin KS, Wiser WL, Morrison JC.
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [Abstract] [Full Text] [Related]

  • 12. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP, Rubin A, Millman AE.
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [Abstract] [Full Text] [Related]

  • 13. Mid-trimester abortion using hypertonic saline or prostaglandin E2 gel: an analysis of efficacy and complications.
    Herabutya Y, O-Prasertsawat P.
    J Med Assoc Thai; 1994 Mar; 77(3):148-52. PubMed ID: 7798849
    [Abstract] [Full Text] [Related]

  • 14. [Gameprost, sulproston and dinoproston for induced abortion in the 15th-24th week of pregnancy].
    Kamali P, Hohmann M, Herrero J, Künzel W.
    Zentralbl Gynakol; 1998 Mar; 120(6):293-300. PubMed ID: 9659700
    [Abstract] [Full Text] [Related]

  • 15. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z, Chwalisz K, Michałkiewicz W.
    Acta Chir Hung; 1986 Mar; 27(3):151-6. PubMed ID: 3825407
    [Abstract] [Full Text] [Related]

  • 16. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS, Savage K, Lincoln T, Owen J.
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [Abstract] [Full Text] [Related]

  • 17. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M, Amy JJ, Decoster JM.
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [Abstract] [Full Text] [Related]

  • 18. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J, Surrago EJ.
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [Abstract] [Full Text] [Related]

  • 19. The use of prostaglandins and their analogues for abortion.
    Bygdeman M.
    Clin Obstet Gynaecol; 1984 Dec; 11(3):573-84. PubMed ID: 6391777
    [Abstract] [Full Text] [Related]

  • 20. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M, Laufe LE.
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.